3'-O-[tert-Butyl(dimethyl)silyl]thymidine>98.0%(HPLC)(T)250mg

2,3-Dichloropyridine-4-boronic acid, 95.0%, 25g

[5-(4-methylphenyl)isoxazol-3-yl]methanol, 95.0%, 250mg

tert-Butyl (2-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)carbamate, 95.0%, 25g

Sesamol>98.0%(GC)25g

1-(3-METHOXY-4-METHYLPHENYL)CYCLOPENTANECARBOXYLIC ACID, 95%, 100mg

Methyl 2-amino-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)nicotinate, 95.0%, 5g

1-(1H-1,2,3-Benzotriazol-1-ylmethyl)pyrrolidine-2-thione, 100mg

2-Chloro-6-(trifluoromethyl)benzaldehyde, 95.0%, 5g

1-benzyl-N-[(pyridin-4-yl)methyl]piperidin-4-amine dihydrochloride, 95.0%, 1g

4-Amino-4-methyl-1-Boc-piperidine, 97.0%, 5g

N-Cyclobutylpiperazine dihydrochloride, 95.0%, 1g

5-methylsalicylic acid, min. 98%, for synthesis, 25 g, plastic packaging.